Liraglutide and a Calorie Restricted Diet Augments Weight Loss and Decreases Risk of Type 2 Diabetes and CVD.

Clinical trial NCT01784965 · COMPLETED

Trial details

NCT number: NCT01784965
Sponsor: Stanford University
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pre-diabetes Older Adults

Start date: 2009-12-01
Primary completion: 2012-12-01
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.